USE CASE: Exploring the Opioid Epidemic

The College of Pharmacy is affiliated with both Oregon State University (OSU) and Oregon Health and Sciences University (OHSU).

Project Summary: With opioid overdose deaths rising every year, OSU researchers investigated ways to end the epidemic. During the years analyzed, Oregon Medicaid had a daily dose limit on prescribing opioid painkillers to members. At the time, Colorado did not have a similar policy in place, though there were quantity limits on short-acting and long-acting opioids.

Researchers compared opioid prescription and adverse outcome information between the two states to see if there was a correlation between the prescription restriction and opioid abuse. Results of the study indicated that while the prescription restriction did not reduce opioid overdoses, it did reduce the number of opioid prescriptions.

Benefit to Colorado: This study highlighted evidence that could support Health First Colorado (Colorado’s Medicaid Program) investigating whether a dose restriction policy has any effect on the opioid crisis. Information such as this can inform policy designed to make Coloradans healthier.

 

Related Posts

CO APCD

Plaintalk Blog: What is actually in the CO APCD? Part 2: Health Insurance Professional Claims

This is the second in a series of blogs about what, exactly, is in the Colorado All Payer Claims Database (CO APCD). Today we’re looking at professional claims, which are generally used by providers in Read more…

Blog

Change Agent Chat: Children’s Colorado

Children’s Hospital Colorado Children’s Hospital Colorado is using CO APCD data to assess variation in care for children with medical complexity (CMC) who have medical fragility and intense medical and coordination of care needs that Read more…

Blog

Plaintalk Blog: How Healthy are Coloradans?

Two of the big draws to living in Colorado are the sunny days and endless opportunities to enjoy the outdoors. Unfortunately, not everyone can take full advantage of what Colorado has to offer when limited Read more…